Specialists of “Fitolon” developed, organized production and put into practice new drug “Mamoklam” for the treatment of all forms of mastopathy.Fitolon is a research and manufacturing company established in
Saint Petersburg in 1990. Our company develops therapeutic and preventative biopharmaceuticals, tests them, and implements these medications into practice. This work results from long-term studies of bioactive substances by the S.M. Kirov Forestry Engineering Academy, the V.L. Komarov Botanical Institute (Saint Petersburg) and other Russian research centers. In the 1930s, Professor F.T. Solodkiy from the Forestry Engineering Academy developed a unique technology to obtain biologically active substances from foliage in order to derive and concentrate most valuable components. Before the World War II, drugs, medical ointments, toothpastes, cosmetics, and others were produced due to this technology. In sieged Leningrad, using Solodkiy’s technology, the Forestry Engineering Academy made acerose ‘elixir of life’ and transported it by sledges to hospitals, those way saved many wounded and debilitated people.
Fitolon improved the technology of deriving of biologically active substances from herbal raw materials and applied it to seaweeds . Our high-class professionals, such as scientists, physicians, pharmacists, technologists, manufacturers, marketologists, actively co-operate with Russia’s leading research institutions and practical healthcare organizations. Today the company has patented unique processing technologies for seaweed and other plant materials.
The company has organized the industrial production on the basis of its development in the specialized enterprises of Russia.Fitolon uses world’s leading technologies for processing seaweeds and obtaining concentrated products. Fitolon is the leading manufacturer, of seaweed therapeutic and preventative pharmaceuticals.
The World Ocean is getting more and more polluted. Seaweeds accumulate both useful and toxic substances from seawater. For instance, a serious issue is an elevated level of arsenic in seaweeds. Fitolon produces seaweed concentrates that does not contain any toxic components. The company is working to improve the technology of seaweed concentrate production and guarantees a high quality of the products. A wide range of biologically active substances, pollutant-free content, and high quality are hallmarks of the products manufactured by our technology .
The medicinal product Mamoclam passed clinical tests at the Prof. N.N.Petrov Research Institute of Oncology under the Ministry of Healthcare of Russia ( Saint Petersburg), the Research Center for Obstetrics, Gynecology, and Perinatology under the Russian Academy of Medical Sciences (Moscow), and the Municipal Mammology Dispensary under the Committee of Healthcare of Moscow.
The owner of the Mamoclam patents is the research and manufacturing firm Fitolon-Nauka,. Saint Petersburg The
manufacturer of the medication Mamoclam is MegaFarm CJSC.